跳至主要内容
临床试验/NL-OMON50969
NL-OMON50969已完成4 期

Determining the clinical relevance of the inTeraction between AprepitaNt aNd EtoposiDe; an observational pharmacokinetic study (TANNED-study) - TANNED

Afdeling Apotheek0 个研究点目标入组 12 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patients with TC who will start or already started treatment with (B)EP
  • Age of at least 18 years
  • Patients from whom it is possible to collect blood samples
  • Patients who are able and willing to give written informed consent prior to

排除标准

  • Patients who are co-treated with drugs that could interfere with the
  • metabolism of etoposide (including drugs classified as a weak, moderate or
  • strong CYP3A4 inhibitor OR weak, moderate and strong inducers of CYP3A4
  • according to the table based on the Flockhart table).

研究者

发起方
Afdeling Apotheek

相似试验